October 18, 2022

Vitiligo may be a complication of treatment for psoriasis. In one case study, a patient being treated with ixekizumab for psoriasis developed vitiligo, which may be due to the drug’s mechanism of action. Vitiligo is an acquired depigmenting skin disorder characterized by melanocyte loss and low health-related quality of life. Psoriasis, another autoimmune skin disease,...

Researchers have found that transplantation of melanocytes in conjunction with dermabrasion is effective for treating vitiligo. This new treatment technique can be considered a viable option that healthcare providers can recommend to their patients with vitiligo. Vitiligo is a chronic, inflammatory skin disease that causes depigmented patches on the skin. These patches are caused by...

Metabolic syndrome may be associated with vitiligo in different age groups. One study suggests that vitiligo may be a risk factor for metabolic dysfunction, which may warrant the need for screening in some patients. In the last few decades, links between systemic vitiligo and potential metabolic disturbances have caused some concern. Based on the criteria...